Latest Non-alcoholic fatty liver disease Stories
NIH-funded, NEJM study is largest ever to look at nonalcoholic steatohepatitis, an obesity-related condition.
A daily dose of a specific form of vitamin E significantly improved the liver disease, nonalcoholic steatohepatitis (NASH), according to a study funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health.
Modifying risk factors essential in controlling liver disease progression.
Encouraging results in 1 male subgroup may guide future clinical practice.
Results show highly significant dose dependent response.
Children with more body fat and less endurance than their fitter, leaner counterparts have stiffer arteries at a young age.
NAFLD and NASH patients at greater risk of death than the general population.
Sonic detection of liver stiffness emerges as a useful screening and prognostic test.
Findings suggest patients with nonalcoholic liver disease are candidates for transplants, but are at increased risk for metabolic syndrome complications.
Impaired oxidation in liver associated with progression to NASH.
- The act of sweetening by admixture of some saccharine substance.